Aspergilus Galactomannan Lateral Flow Assay
- UID
- IMP/IVD/2019/000296_a253976b943e870d9dee7a07b87393f8_bfd95e1b51dff54e4a852df4aec3941d
- Device class
- Class C
- Brand name
- sona Aspergillus GM LFA
- License holder
- Taevas Life Sciences Private Limited
- Approving authority
- CDSCO
- Product information
- The sona Aspergillus Galactomannan Lateral Flow Assay (sona Aspergillus GM LFA) is an immunochromatographic test system for the qualitative detection of Aspergillus Galactomannan in serum and BAL samples. The sona Aspergillus GM LFA is a test which, when used in conjunction with other diagnostic procedures such as microbiological culture, histological examination of biopsy samples, and radiographic evidence, can be used as an aid in the diagnosis of aspergillosis
Aspergilus Galactomannan Lateral Flow Assay is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000296_a253976b943e870d9dee7a07b87393f8_bfd95e1b51dff54e4a852df4aec3941d. This device is marketed under the brand name sona Aspergillus GM LFA. The license holder is Taevas Life Sciences Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.